http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f3358af9e78a61954b333fa3e75c41d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Joshua |
| name | Anthony M. Joshua Anthony M Joshua |
| given-name | Anthony M. Anthony M |
| organization-name | Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2C1, Canada; Kinghorn Cancer Centre, St. Vincent’s Hospital Sydney, Darlinghurst, New South Wales 2010, Australia Princess Margaret Hospital, Medical Oncology, Toronto, Ontario, Canada Medical Oncology and Hematology; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincents Hospital; Melanoma Institute of Australia, Sydney, Australia Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C1, Canada; Department of Medical Oncology, Kinghorn Cancer Centre, Darlinghurst, NSW 2010, Australia Princess Margaret Cancer Centre 610 University Avenue. M5G2M9 Toronto Canada; Kinghorn Cancer Centre St Vincents Hospital Sydney Australia Department of Medical Oncology (A.M.J., S.E., R.B., J.J.K.), Princess Margaret Hospital, University Health Network, M5G 2M9 Toronto, Ontario, Canada 5Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. Authors' Affiliations: 1Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; 2Radiation Medicine Program, Princess Margaret Hospital, University Health Network; 3Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; 4Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; 5Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; 6Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; 7Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; 8Division of Urology, University of Montreal Health Center, Montreal, Quebec; 9Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and 10Department of Pathology and Laboratory Medicine and Oncology, Un Caroline Robert, Gustave Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Adil Daud, University of California, San Francisco, San Francisco, CA; Jedd D. Wolchok, Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY; Anthony M. Joshua, The Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Wen-Jen Hwu, The University of Texas MD Anderson... Kyaw L. Aung, Philippe L. Bedard, Celeste Yu, Scott L. Boerner, Sangeet Ghai, Hal K. Berman, Stefano Serra, Amanda Giesler, Lailah Ahmed, Anthony M. Joshua, Amit M. Oza, Eitan Amir, Tong Zhang, Mahadeo A. Sukhai, Tracy L. Stockley, Suzanne Kamel-Reid, Lillian L. Siu, and Aaron R. Hansen, University Health Network; Philippe L. Bedard, Amit M. Oza, Eitan Amir, Tracy L. Stockley, Suzanne Kamel-Reid, Lillian L. Siu, and Aaron R. Hansen, University of Toronto; Philip C. Zuzarte, Ontario Institute of Cancer... Princess Margaret Cancer Centre, Toronto, ON, Canada. 3Princess Margaret Cancer Centre, Toronto, Canada. 7Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; 8Department of Medical Oncology, Kinghorn Cancer Centre, Sydney, Australia. Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center; Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY; Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris; Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France; Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands; Stephen Frank, Hebrew University Hadassah Medical School – The Sharett Institute of Oncology, Jerusalem; Jacob Schachter, Sheba... From the Divisions of Medical Oncology/Hematology, Thoracic Surgery, and Chest Imaging, and the Department of Pathology, Princess Margaret Hospital/University Health Network; Applied Molecular Oncology, Applied Molecular Profiling Laboratory, and Biostatistics, Ontario Cancer Institute; and the Institute of Medical Sciences and Departments of Surgery, Laboratory Medicine and Pathobiology, Medical Imaging, and Medicine, University of Toronto, Toronto, Ontario, Canada. Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia; Garvan Institute of Medical Research, Sydney, Australia Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; Drug Development Program, Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada From the Angeles Clinic and Research Institute (O.H., P.B.) and the University of California, Los Angeles (P.C.T., B.C., A.R.) — both in Los Angeles; Institute Gustave Roussy, Villejuif, France (C.R., C.M.); University of California, San Francisco, San Francisco (A.D., A.A.); Dana–Farber Cancer Institute, Boston (F.S.H.); University of Texas M.D. Anderson Cancer Center, Houston (W.-J.H.); Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney (R.K.), and Kolling Institute,... Kinghorn Cancer Centre St. Vincent's Hospital Darlinghurst NSW Australia; Garvan Institute of Medical Research Darlinghurst NSW Australia; University of New South Wales St. Vincent's Clinical School Darlinghurst NSW Australia University Health Network/Princess Margaret Cancer Centre Toronto Ontario Canada St Vincent’s Hospital, Kensington, New South Wales, Australia; University of New South, Darlinghurst, New South Wales, Australia; University of New South Wales, Kensington, New South Wales, Australia Garvan Institute of Medical Research Sydney NSW Australia; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group Sydney NSW Australia; Department of Medical Oncology The Kinghorn Cancer Centre St Vincent’s Hospital Sydney NSW Australia Department of Medical Oncology and Haematology Princess Margaret Cancer Centre Toronto Ontario Canada Department of Medical Oncology Kinghorn Cancer Centre St Vincent’s Hospital Sydney NSW Australia 5Kinghorn Cancer Center, St. Vincent's Hospital, Sydney, NSW, Australia.; 6Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.; 7Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee... Princess Margaret Cancer Centre and University of Toronto; Toronto Ontario Melanoma Institute Australia Sydney New South Wales Australia; Kinghorn Cancer Centre St Vincent’s Hospital Sydney New South Wales Australia St Vincents Hospital Sydney Australia Department of Medical Oncology, Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia Medical Oncology The Kinghorn Cancer Centre at St Vincent's Hospital/Garvan Institute of Medical Research Sydney Australia Department of Medical Oncology and Hematology; Princess Margaret Cancer Center; University Health Network; Toronto Canada Princess Margaret Cancer Centre University Health Network Toronto Canada; Division of Medical Oncology and Hematology Department of Medicine University of Toronto Toronto Canada; Department of Medical Oncology Kinghorn Cancer Centre St Vincents Hospital and Garvan Institute of Medical Research Sydney Australia Authors' Affiliations: 1Ontario Cancer Institute/Princess Margaret Hospital (University Health Network); 2Departments of Laboratory Medicine and Pathology, and 3Medical Biophysics and Radiation Oncology, University of Toronto, Toronto, Canada; 4Cancer Research UK/MRC Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom; and 5Departments of Pathology & Laboratory Medicine and Oncology, University of Calgary and Southern Alberta Cancer Institute, Calgary, Alberta, Canada Department of Medical Oncology Kinghorn Cancer Centre St. Vincent's Hospital University of New South Wales, Darlinghurst Sydney New South Wales Australia Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada The Kinghorn Cancer Centre Darlinghurst New South Wales Australia Kinghorn Cancer Centre, St Vincent’s Hospital, Sydney, New South Wales, Australia F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco... Department of Medicine University Health Network Toronto Ontario Canada; Kinghorn Cancer Centre University of New South Wales Sydney New South Wales Australia Medical Oncology Department, Kinghorn Cancer Centre, St. Vincent’s Hospital Sydney, Darlinghurst, Australia. Princess Margaret Cancer Centre, Toronto, Ontario, Canada St Vincent's Hospital Sydney Australia Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia; Garvan Institute of Medical Research, Sydney, Australia. From the University Hospital Heidelberg, Heidelberg (J.C.H.), the Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, Munich (M.S.), and the Department of Dermatology, Venereology, and Allergology (M.S.) and the Department of Hematology, Oncology, and Tumor Immunology and the Comprehensive Cancer Center (S.O.), Charité–Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and the Department of Hematology, Oncology, and Tumor... Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Medical Oncology, Princess Margaret Hospital, Toronto, Canada. From the Department of Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada; Department of Social Work, Royal Prince Alfred Hospital, Sydney; and Central Clinical School, University of Sydney, Sydney, Australia Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent’s Hospital Sydney; School of Clinical Medicine, UNSW Medicine and Health, St Vincent’s Hospital, Darlinghurst; Melanoma Institute Australia, University of Sydney, North Sydney, NSW, Australia Department of Medical Oncology and Haematology, St Vincent's Hospital, University of New South Wales, Sydney, Australia 1Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada.; 19Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia. The Kinghorn Cancer Centre, St Vincent’s Hospital, Sydney, NSW, Australia |
Incoming Links
Total number of triples: 195.